• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P 选择素配体诱导血小板活化,增强微聚集体和血栓形成。

P-selectin ligation induces platelet activation and enhances microaggregate and thrombus formation.

机构信息

Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada.

出版信息

Thromb Res. 2011 Sep;128(3):243-50. doi: 10.1016/j.thromres.2011.04.018. Epub 2011 May 19.

DOI:10.1016/j.thromres.2011.04.018
PMID:21600632
Abstract

INTRODUCTION

Platelet P-selectin is a thrombo-inflammatory molecule involved in platelet activation and aggregation. This may occur via the adhesive function of P-selectin and its potential capacity to trigger intracellular signaling. However, its impact on platelet function remains elusive. This study was therefore designed to investigate the relationship between the signaling potential of platelet P-selectin and its function in platelet physiology.

METHODS AND RESULTS

Human and mouse platelets were freshly isolated from whole blood. Platelet activation was assessed using flow cytometry and western blot analysis, while platelet physiological responses were evaluated through aggregation, microaggregate formation and in a thrombosis model in wild-type and P-selectin-deficient (CD62P(-/-)) mice. Interaction of P-selectin with its high-affinity ligand, a recombinant soluble form of P-Selectin Glycoprotein Ligand-1 (rPSGL-1), enhances platelet activation, adhesion and microaggregate formation. This augmented platelet microaggregates requires an intact cytoskeleton, but occurs independently of platelet α(IIb)β(3). Thrombus formation and microaggregate were both enhanced by rPSGL-1 in wild-type, but not in CD62P(-/-) mice. In addition, CD62P(-/-) mice exhibited thrombosis abnormalities without an α(IIb)β(3) activation defect.

CONCLUSIONS

This study demonstrates that the role of platelet P-selectin is not solely adhesive; its binding to PSGL-1 induces platelet activation that enhances platelet aggregation and thrombus formation. Therefore, targeting platelet P-selectin or its ligand PSGL-1 could provide a potential therapeutic approach in the management of thrombotic disorders.

摘要

简介

血小板 P-选择素是一种参与血小板激活和聚集的血栓炎症分子。这可能通过 P-选择素的黏附功能及其触发细胞内信号的潜在能力来实现。然而,其对血小板功能的影响仍不清楚。因此,本研究旨在探讨血小板 P-选择素的信号潜能与其在血小板生理中的功能之间的关系。

方法和结果

从全血中新鲜分离出人源和鼠源血小板。通过流式细胞术和 Western blot 分析评估血小板激活,通过聚集、微聚集形成和在野生型和 P-选择素缺陷型(CD62P(-/-))小鼠的血栓模型中评估血小板生理反应。P-选择素与其高亲和力配体,重组可溶性 P-选择素糖蛋白配体-1(rPSGL-1)的相互作用增强了血小板的激活、黏附和微聚集形成。这种增强的血小板微聚集需要完整的细胞骨架,但不依赖于血小板α(IIb)β(3)。rPSGL-1 在野生型小鼠中增强了血栓形成和微聚集,但在 CD62P(-/-) 小鼠中没有。此外,CD62P(-/-) 小鼠表现出血栓形成异常,而没有α(IIb)β(3)激活缺陷。

结论

本研究表明,血小板 P-选择素的作用不仅是黏附性的;其与 PSGL-1 的结合诱导血小板激活,增强血小板聚集和血栓形成。因此,靶向血小板 P-选择素或其配体 PSGL-1 可能为血栓性疾病的治疗提供一种潜在的方法。

相似文献

1
P-selectin ligation induces platelet activation and enhances microaggregate and thrombus formation.P 选择素配体诱导血小板活化,增强微聚集体和血栓形成。
Thromb Res. 2011 Sep;128(3):243-50. doi: 10.1016/j.thromres.2011.04.018. Epub 2011 May 19.
2
Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation.猪内皮细胞对异种血清的激活反应会导致血栓形成,且与血小板激活无关。
Xenotransplantation. 2005 Mar;12(2):110-20. doi: 10.1111/j.1399-3089.2005.00203.x.
3
P-selectin antagonism with recombinant p-selectin glycoprotein ligand-1 (rPSGL-Ig) inhibits circulating activated platelet binding to neutrophils induced by damaged arterial surfaces.用重组P-选择素糖蛋白配体-1(rPSGL-Ig)拮抗P-选择素可抑制循环中活化血小板与受损动脉表面诱导的中性粒细胞的结合。
J Pharmacol Exp Ther. 2001 Aug;298(2):658-64.
4
Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates.血小板P-选择素通过形成大量稳定的血小板-白细胞聚集体在动脉血栓形成中起重要作用。
J Am Coll Cardiol. 2005 Apr 19;45(8):1280-6. doi: 10.1016/j.jacc.2004.12.071.
5
Neutrophil P-selectin-glycoprotein-ligand-1 binding to platelet P-selectin enhances metalloproteinase 2 secretion and platelet-neutrophil aggregation.中性粒细胞P-选择素糖蛋白配体-1与血小板P-选择素的结合增强金属蛋白酶2的分泌及血小板-中性粒细胞聚集。
Thromb Haemost. 2005 Dec;94(6):1230-5. doi: 10.1160/TH05-05-0344.
6
Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation.血小板P-选择素和微粒PSGL-1在血栓形成中的作用。
Trends Mol Med. 2004 Apr;10(4):171-8. doi: 10.1016/j.molmed.2004.02.008.
7
The periodontal anaerobe Porphyromonas gingivalis induced platelet activation and increased aggregation in whole blood by rat model.牙周厌氧菌牙龈卟啉单胞菌通过大鼠模型诱导全血中的血小板活化和聚集增加。
Thromb Res. 2011 May;127(5):418-25. doi: 10.1016/j.thromres.2010.12.004. Epub 2011 Feb 18.
8
Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation.血小板拥有并需要一条活跃的蛋白质棕榈酰化途径,用于激动剂介导的激活和体内血栓形成。
Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1478-85. doi: 10.1161/ATVBAHA.106.139287. Epub 2007 Feb 15.
9
Redistribution of P-selectin ligands on neutrophil cell membranes and the formation of platelet-neutrophil complex induced by hemodialysis membranes.血液透析膜诱导中性粒细胞细胞膜上P-选择素配体的重新分布及血小板-中性粒细胞复合物的形成。
Biomaterials. 2008 Jul;29(21):3084-90. doi: 10.1016/j.biomaterials.2008.04.018. Epub 2008 May 2.
10
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.组织因子在体内发展中的血栓内的积累取决于微粒P-选择素糖蛋白配体1和血小板P-选择素。
J Exp Med. 2003 Jun 2;197(11):1585-98. doi: 10.1084/jem.20021868.

引用本文的文献

1
Acoustofluidic system for targeted antibody removal in transplantation: Enabling small-volume therapeutic apheresis.用于移植中靶向抗体去除的声流体系统:实现小容量治疗性血液成分单采。
Sci Adv. 2025 Sep 5;11(36):eady3262. doi: 10.1126/sciadv.ady3262.
2
Platelet-Related Biomarkers and Efficacy of Antiplatelet Therapy in Patients with Aortic Stenosis and Coronary Artery Disease.血小板相关生物标志物与主动脉瓣狭窄合并冠状动脉疾病患者抗血小板治疗的疗效
Int J Mol Sci. 2025 Jul 23;26(15):7083. doi: 10.3390/ijms26157083.
3
Phytochemicals profile, cellular viabillity and platelet activity of Linn. leaf extract: ex vivo .
Linn.叶提取物的植物化学特征、细胞活力及血小板活性:离体研究
J Oral Biol Craniofac Res. 2025 Sep-Oct;15(5):1083-1090. doi: 10.1016/j.jobcr.2025.07.008. Epub 2025 Jul 23.
4
P-selectin glycoprotein ligand-1 and cardiovascular diseases: from a general perspective to an HIV infection context.P-选择素糖蛋白配体-1与心血管疾病:从一般视角到人类免疫缺陷病毒感染背景
Front Cardiovasc Med. 2025 Feb 18;12:1521158. doi: 10.3389/fcvm.2025.1521158. eCollection 2025.
5
Characterization of Platelet Receptors and Their Involvement in Immune Activation of These Cells.血小板受体的特征及其在这些细胞免疫激活中的作用
Int J Mol Sci. 2024 Nov 24;25(23):12611. doi: 10.3390/ijms252312611.
6
Platelet activation through CD62P and the formation of platelet-monocyte complexes are associated with the exacerbation of mucosal inflammation in patients with ulcerative colitis.血小板通过 CD62P 的激活和血小板-单核细胞复合物的形成与溃疡性结肠炎患者黏膜炎症的恶化有关。
Sci Rep. 2024 Nov 14;14(1):28055. doi: 10.1038/s41598-024-78462-8.
7
Newer Modalities and Updates in the Management of Sickle Cell Disease: A Systematic Review.镰状细胞病管理中的新型治疗方法与进展:一项系统综述
J Blood Med. 2024 Sep 12;15:435-447. doi: 10.2147/JBM.S477507. eCollection 2024.
8
Acoustofluidic-based therapeutic apheresis system.基于声流的治疗性血液分离系统。
Nat Commun. 2024 Aug 10;15(1):6854. doi: 10.1038/s41467-024-50053-1.
9
The Role of Biomarkers, Metabolomics, and COVID-19 in Venous Thromboembolism-A Review of Literature.生物标志物、代谢组学与 COVID-19 在静脉血栓栓塞症中的作用——文献综述
Int J Mol Sci. 2023 Aug 29;24(17):13411. doi: 10.3390/ijms241713411.
10
Deferiprone, an iron chelator, alleviates platelet hyperactivity in patients with β-thalassaemia/HbE.去铁酮,一种铁螯合剂,可减轻β地中海贫血/HbE患者的血小板高活性。
Drugs Context. 2022 Dec 12;11. doi: 10.7573/dic.2022-7-6. eCollection 2022.